The high prevalence of both Helicobacter.pylori infection and coronary atherosclerosis in our country prompted us to assess the probable association between both conditions. This cross-sectional study recruited 153 patients scheduled to undergo coronary artery angiography. Patients were divided into two groups on the basis of coronary angiography results. Sixty-nine patients had coronary atherosclerosis and the 84 remaining patients were normal. Characteristics and pre-angiographic serum levels of triglyceride, lowdensity lipoprotein cholesterol, high-density lipoprotein, and Helicobacter.pylori IgG antibody were assessed in the patients and compared between the groups. Helicobacter.pylori infection occurred in 88 (57.51%) patients: 40 (58%) in the atherosclerotic group and 48 (57.1%) in the control group with no significant differences (P=0.918). Our multivariable analysis revealed that Helicobacter.pylori infection was not an independent predictive factor for coronary artery disease (P =0.915). Also, the prevalence of atherosclerosis risk factors with respect to the seropositive and seronegative Helicobacter.pylori infection was assessed in the case group, which showed no significant difference. Furthermore, the prevalence of seropositive Helicobacter.pylori infection in terms of the number of diseased coronary vessels was evaluated, this demonstrated no significant association between the number of the diseased vessels and Helicobacter.pylori infection. This study demonstrated that Helicobacter.pylori infection was not an independent predictive factor of atherosclerosis.
Introduction
Atherosclerosis is a principal cause of death all over the world [1, 2] . Several studies have thus far sought to identify the predictors of atherosclerosis, with more recent publications focusing on the inflammatory effects of infectious agents such as Chlamyda.pneumoniae and Helicobacter.pylori (H.pylori) on atherosclerosis. Despite all those efforts, however, controversy still abounds about the role of H.pylori as a determinant factor of atherosclerosis and ischemic disease [3] [4] [5] [6] [7] [8] [9] .
H.pylori is a gram-negative micro-aerophilic spiral bacterium that survives and colonizes in the human gastric mucosa layer. It leads to range of diseases comprising gastritis and gastric ulcers, cancers, and lymphomas [10] [11] [12] . Infection with H.pylori occurs worldwide with a prevalence spectrum from 20-50% in industrial countries to 80% in developing countries [10, 13] . As a developing country, Iran is burdened with a high prevalence of H.pylori infection and atherosclerosis. A lot of research is made to find the exact predictors of young age atherosclerosis in our society and H.pylori infection is one of noticeable suggestion. We, therefore, conducted the present study to evaluate the possible correlation between H.pylori infection and atherosclerosis in our population.
Material and Methods
This cross-sectional study, conducted from April 2006 to April 2007, recruited 153 adult patients scheduled for coronary angiography. The study was approved by our hospital ethics committee, and informed consent was obtained from all the patients.
Patients with a history of valvular disease, atherosclerotic cardiomyopathy, and antibiotic therapy against H.pylori infections were excluded from the study.
The patients were divided into two groups with and without coronary artery disease (CAD) according to the diagnosis of CAD based on coronary angiography.
Demographic characteristics, comprised of age, sex, body mass index (BMI), history of diabetes mellitus, hypertension, hypercholesterolemia, family history of atherosclerotic disease, and cigarette smoking habit, were assessed in the patients and compared between the groups. Additionally, the serum levels of triglyceride (TG), lowdensity lipoprotein cholesterol (LDL), high-density lipoprotein (HDL) were routinely measured before angiography for all patients.
Coronary artery disease
The diagnosis of CAD was based on coronary angiography results. CAD was diagnosed if ≥50% stenosis was detected in at least one coronary artery. All the coronary angiographies were performed by the same cardiologist in our center.
2.2.
Helicobacter. pylorispecific immunoglobulin G antibody (H.pylori IgG antibody):
Two milliliters of blood were taken from all the patients and kept in -80 °C.
H.pylori IgG antibody titers were measured by the enzyme-linked immunosorbent assay (ELISA) method using the commercial kit of Euroimmune (Germany).
According to the manufacturer's instruction, patients with IgG antibody titers higher than 22 Ru/ml were considered seropositive for H.pylori infection.
Statistical analysis
The univariate analysis of the continuous variables was carried out by Student's t-test, and the categorical variables were compared via the chi-square test and Fisher's exact test, as appropriate. The variables were included into a multivariate logistic regression model, and the association of the independent predictors with CAD in the final model was expressed as odds ratio 
Results
A total of 153 patients, who underwent coronary angiography, were enrolled into the study. The patients consisted of 55 (35.9%) women and 98 (34.1%) men at a mean age of 58.8±9.64 years. CAD was diagnosed in 69 patients (case group), and the remaining 84 patients had normal coronary vessels (control group). The mean age, BMI, diabetes mellitus, hypertension, hypercholesterolemia, family history of atherosclerotic disease, and TG serum level were not significantly different between the two groups. But there was a statistically significant difference between the groups in regards to sex distribution, cigarette smoking habit, HDL, and LDL serum levels. Assessment of H.pylori IgG antibody titers revealed that H.pylori infection totally occurred in 88 (57.51%) patients: 40 (58%) in the atherosclerotic group and 48 (57.1%) in the control group. There was no significant difference between two groups (P-value=0.918) ( Table 1) . Also, the prevalence of seropositive H.pylori infection were evaluated in patients according to the sex and smoking habit which did not show any significant difference between the groups (Tables 2 and 3 ). The multivariable analysis demonstrated that age, female gender, LDL, and HDL are only the predictive factors of CAD and H.pylori infection was not an independent predictive factor for CAD (P-value=0.915) ( Table 4) .
Additionally, the prevalence of CAD risk factors in the case group was compared between seropositive and seronegative subgroups, which were not indicative of any significant difference between the groups ( Table 5 ). The prevalence of seropositive H.pylori infection with respect to the number of diseased coronary vessels was also evaluated, which showed no significant association between the number of diseased vessels and H.pylori infection (Table 6 ).
Discussion
The vast array of studies performed thus far has brought about conflicting results and controversies. These inconsistencies may well have been a consequence of different evaluation methods for H.pylori infection and atherosclerosis or even different populations recruited into the studies. In the present study, H.pylori infection was evaluated by measuring IgG antibody titers via the ELISA in patients in whom atherosclerosis was assessed by coronary angiography. The prevalence of H.pylori infection was 57.51% in the study population: 58% in the atherosclerotic group and 57.1% in the control group. The prevalence of H.pylori infection in normal and atherosclerotic patients in different areas of our country has been reported to be within a wide range of 16%-72.2% and 39.4%-70%, respectively [9, 14, 15] . This sizable difference in range may have resulted from the difference in the measuring factors of infection such as IgA and IgG antibodies, which can detect different phases of infection, and the use of different tests such as urease respiratory test and cytotoxin-associated gene-A (Cag A) with their different sensitivity and specificity. Another likely culprit is the different prevalence of H.pylori infection in different geographical areas and socioeconomic conditions of a country. Our hospital, a referral center in Iranian capital city of Tehran, admits patients from all parts of the country; the prevalence obtained in the present study could, therefore, be deemed the average prevalence of the H.pylori infection for the country.
Our multivariable analysis showed no significant correlation between H.pylori infection and atherosclerosis. While these results are similar to some previously published studies [5, 8, [16] [17] [18] [19] [20] , it is not concordant with others [9, [21] [22] [23] [24] [25] [26] [27] [28] . It is worth repeating that this discrepancy seems to have arisen from the previously various methods of evaluating H.pylori infection and atherosclerosis. For instance, there are studies in the medical literature [21, [23] [24] [25] ] that either did not use coronary angiography for detecting atherosclerosis or only use it for case groups with myocardial infarction. There are studies [22] whose study population was selected from patients admitted into cardiac clinics due to clinical symptoms of heart burn or angina pectoris. It is likely that some of these symptoms were secondary to gastric diseases and H.pylori infection, hence the higher prevalence of infection in these patients. It could, therefore, be argued that these factors exerted inappropriate effects on the results. Because there are deleterious effects of H.pylori infection on coronary atherosclerosis risk factors [29] [30] [31] [32] [33] , we decided to divide the case group patients in terms of seropositive and seronegative H.pylori infection. The result showed no significant difference in the risk factors between the two groups, and it does not agree with some theories [34] .
As we evaluated atherosclerosis using coronary angiography and H.pylori infection using IgG antibody serum level, the results give the impression of reliability. Nonetheless, Bazazi and colleagues 9 illustrated that atherosclerosis has a correlation with seropositive IgA H.pylori infection and did not detect any correlation with seropositive IgG H.pylori infection.
We did not evaluate highly virulent strains of H.pylori which create Cag A toxin and thus induce severe infection. However, some studies have reported association with atherosclerosis [3, 26, 28, 35] , some others have reported the non-significant role of anti-Cag A antibody in ischemic heart disease [5, 7, 36] . Future studies are required to shed sufficient light upon this particular point.
In light of the previously mentioned results, we would suggest that H.pylori infection is not an independent predictive factor of atherosclerosis until further studies have clarified its effect on atherosclerosis.
